Publications searcher The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points. Fulltext search Alphabetic A-Z Alphabetic Z-A New era for European Respiratory Society clinical practice guidelines: joining efficiency and high methodological standards. PMID: 29519905 Journal: EUROPEAN RESPIRATORY JOURNAL Year: 2018 Reference: Eur Respir J. 2018 Mar 8;51(3). pii: 51/3/1800221. doi: 10.1183/13993003.00221-2018. Print 2018 Mar. Impact factor: Publication type: Editorail in international publication Authors: Brusselle, Guy; Gaga, Mina; Genton, Celine; Miravitlles, Marc; Rigau, David; Roche, Nicolas; Tonia, Thomy; Vaccaro, Valerie; Welte, Tobias et al. DOI: 10.1183/13993003.00221-2018 New functions of Semaphorin 3E and its receptor PlexinD1 during developing and adult hippocampal formation. PMID: 29358640 Journal: Scientific Reports Year: 2018 Reference: Sci Rep. 2018 Jan 22;8(1):1381. doi: 10.1038/s41598-018-19794-0. Impact factor: 4.122 Publication type: Paper in international publication Authors: Mata, Agata, Gil, Vanessa, Perez-Clausell, Jeus, Dasilva, Miguel, Gonzalez-Calixto, Mari Carmen, Soriano, Eduardo, Garcia-Verdugo, Jose Manuel, Sanchez-Vives, Maria V, Del Rio, Jose Antonio et al. DOI: 10.1038/s41598-018-19794-0 New functions of Semaphorin 3E and its receptor PlexinD1 during developing and adult hippocampal formation. PMID: 29358640 Journal: Scientific Reports Year: 2018 Reference: Sci Rep. 2018 Jan 22;8(1):1381. doi: 10.1038/s41598-018-19794-0. Impact factor: Publication type: Paper in international publication Authors: Dasilva, Miguel; Del Rio, Jose Antonio; Garcia-Verdugo, Jose Manuel; Gil, Vanessa; Gonzalez-Calixto, Mari Carmen; Mata, Agata; Perez-Clausell, Jeus; Sanchez-Vives, Maria V; Soriano, Eduardo et al. DOI: 10.1038/s41598-018-19794-0 New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors. PMID: 29239718 Journal: JOURNAL OF GENERAL VIROLOGY Year: 2018 Reference: J Gen Virol. 2018 Jan;99(1):97-102. doi: 10.1099/jgv.0.000996. Epub 2017 Dec 14. Impact factor: 2.514 Publication type: Paper in international publication Authors: Chen, Qian, Riveiro-Barciela, Mar, Buti, Maria, Esteban, Rafael, Esteban, Juan Ignacio, Rodriguez-Frias, Francisco, Quer, Josep, Llorens, Meritxell, Perales, Celia, Soria, Maria Eugenia et al. DOI: 10.1099/jgv.0.000996 New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors. PMID: 29239718 Journal: JOURNAL OF GENERAL VIROLOGY Year: 2018 Reference: J Gen Virol. 2018 Jan;99(1):97-102. doi: 10.1099/jgv.0.000996. Epub 2017 Dec 14. Impact factor: Publication type: Paper in international publication Authors: Buti, Maria; Chen, Qian; Esteban, Juan Ignacio; Esteban, Rafael; Garcia-Cehic, Damir; Gregori, Josep; Llorens, Meritxell; Nieto-Aponte, Leonardo; Ordeig, Laura; Perales, Celia et al. DOI: 10.1099/jgv.0.000996 News from ASCO 2018. PMID: 30319333 Journal: Breast Care Year: 2018 Reference: Breast Care (Basel). 2018 Aug;13(4):298-302. doi: 10.1159/000491564. Epub 2018 Jul 12. Impact factor: 2.028 Publication type: Letter or abstract Authors: Gampenrieder, Simon, Balic, Marija, Dedic, Natalija, De Mattos-Arruda, Leticia et al. DOI: 10.1159/000491564 News from ASCO 2018. PMID: 30319333 Journal: Breast Care Year: 2018 Reference: Breast Care (Basel). 2018 Aug;13(4):298-302. doi: 10.1159/000491564. Epub 2018 Jul 12. Impact factor: Publication type: Letter or abstract Authors: Balic, Marija; De Mattos-Arruda, Leticia; Dedic, Natalija; Gampenrieder, Simon et al. DOI: 10.1159/000491564 Nilotinib as co-adjuvant treatment with doxorubicin in patients with sarcomas: A phase I trial of the Spanish Group for Research on Sarcoma. PMID: 30037815 Journal: CLINICAL CANCER RESEARCH Year: 2018 Reference: Clin Cancer Res. 2018 Nov 1;24(21):5239-5249. doi: 10.1158/1078-0432.CCR-18-0851. Epub 2018 Jul 23. Impact factor: 10.199 Publication type: Clinical Trials Authors: Alemany, Regina, Moura, David S, Redondo, Andres, Martinez-Trufero, Javier, Calabuig, Silvia, Saus, Carles, Obrador-Hevia, Antonia, Ramos, Rafael F, Villar, Victor H, Valverde, Claudia et al. DOI: 10.1158/1078-0432.CCR-18-0851 Nilotinib as co-adjuvant treatment with doxorubicin in patients with sarcomas: A phase I trial of the Spanish Group for Research on Sarcoma. PMID: 30037815 Journal: CLINICAL CANCER RESEARCH Year: 2018 Reference: Clin Cancer Res. 2018 Nov 1;24(21):5239-5249. doi: 10.1158/1078-0432.CCR-18-0851. Epub 2018 Jul 23. Impact factor: Publication type: Clinical Trials Authors: Alemany, Regina; Calabuig, Silvia; Felipe-Abrio, Irene; Hindi, Nadia; Martin-Broto, Javier; Martinez-Trufero, Javier; Medina, Javier; Moura, David S; Obrador-Hevia, Antonia; Ramos, Rafael F et al. DOI: 10.1158/1078-0432.CCR-18-0851 Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study. PMID: 30010751 Journal: ANNALS OF ONCOLOGY Year: 2018 Reference: Ann Oncol. 2018 Sep 1;29(9):1955-1963. doi: 10.1093/annonc/mdy241. Impact factor: 13.926 Publication type: Paper in international publication Authors: Lonardi, S, Van Cutsem, E, Yoshino, T, Lenz, H J, Saunders, M, Sobrero, A, Park, Y S, Ferreiro, R, Hong, Y S, Tomasek, J et al. DOI: 10.1093/annonc/mdy241 Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study. PMID: 30010751 Journal: ANNALS OF ONCOLOGY Year: 2018 Reference: Ann Oncol. 2018 Sep 1;29(9):1955-1963. doi: 10.1093/annonc/mdy241. Impact factor: Publication type: Paper in international publication Authors: Argiles, G; Ciardiello, F; Falcone, A; Ferreiro, R; Hong, Y S; Lenz, H J; Limon, M L; Lonardi, S; Oum'Hamed, Z; Park, Y S et al. DOI: 10.1093/annonc/mdy241 Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis. PMID: 30220235 Journal: NEW ENGLAND JOURNAL OF MEDICINE Year: 2018 Reference: N Engl J Med. 2018 Nov 1;379(18):1722-1731. doi: 10.1056/NEJMoa1811737. Epub 2018 Sep 15. Impact factor: 79.258 Publication type: Paper in international publication Authors: Glaspole, I, Kolb, Martin, Raghu, Ganesh, Wells, Athol U, Behr, Jurgen, Richeldi, Luca, Schinzel, Birgit, Quaresma, Manuel, Stowasser, Susanne, Martinez, Fernando J et al. DOI: 10.1056/NEJMoa1811737 Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis. PMID: 30220235 Journal: NEW ENGLAND JOURNAL OF MEDICINE Year: 2018 Reference: N Engl J Med. 2018 Nov 1;379(18):1722-1731. doi: 10.1056/NEJMoa1811737. Epub 2018 Sep 15. Impact factor: Publication type: Paper in international publication Authors: Adamali, H; Baba, T; Balestro, E; Behr, Jurgen; Bianchi, S; Bollmann, T; Bondue, B; Bonella, F; Bourdin, A; Church, C et al. DOI: 10.1056/NEJMoa1811737 Nivolumab versus docetaxel in previously treated advanced non-small cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases. PMID: 29408986 Journal: ANNALS OF ONCOLOGY Year: 2018 Reference: Ann Oncol. 2018 Apr 1;29(4):959-965. doi: 10.1093/annonc/mdy041. Impact factor: 13.926 Publication type: Paper in international publication Authors: Gettinger, S, Vokes, E E, Ready, N, Felip, E, Horn, L, Burgio, M A, Antonia, S J, Aren Frontera, O, Waterhouse, D, Domine, M et al. DOI: 10.1093/annonc/mdy041 Nivolumab versus docetaxel in previously treated advanced non-small cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases. PMID: 29408986 Journal: ANNALS OF ONCOLOGY Year: 2018 Reference: Ann Oncol. 2018 Apr 1;29(4):959-965. doi: 10.1093/annonc/mdy041. Impact factor: Publication type: Paper in international publication Authors: Antonia, S J; Aren Frontera, O; Arrieta, O; Barlesi, F; Blumenschein, G Jr; Brahmer, J; Burgio, M A; Butts, C; Chow, L Q M; Coudert, B et al. DOI: 10.1093/annonc/mdy041 NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients. PMID: 29117789 Journal: Multiple Sclerosis Journal Year: 2018 Reference: Mult Scler. 2018 Oct;24(11):1507-1510. doi: 10.1177/1352458517739137. Epub 2017 Nov 9. Impact factor: 5.28 Publication type: Paper in international publication Authors: Malhotra, Sunny, Sorosina, Melissa, Rio, Jordi, Peroni, Silvia, Midaglia, Luciana, Villar, Luisa M, Alvarez-Cermeno, Jose C, Schroeder, Ina, Esposito, Federica, Clarelli, Ferdinando et al. DOI: 10.1177/1352458517739137 NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients. PMID: 29117789 Journal: Multiple Sclerosis Journal Year: 2018 Reference: Mult Scler. 2018 Oct;24(11):1507-1510. doi: 10.1177/1352458517739137. Epub 2017 Nov 9. Impact factor: Publication type: Paper in international publication Authors: Alvarez-Cermeno, Jose C; Clarelli, Ferdinando; Comabella, Manuel; Comi, Giancarlo; Esposito, Federica; Lechner-Scott, Jeannette; Malhotra, Sunny; Martinelli-Boneschi, Filippo; Midaglia, Luciana; Montalban, Xavier et al. DOI: 10.1177/1352458517739137 No Resistance to Tenofovir Alafenamide Detected Through 96 Weeks of Treatment in Patients with Chronic Hepatitis B. PMID: 30038044 Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY Year: 2018 Reference: Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: AAC.01064-18. doi: 10.1128/AAC.01064-18. Print 2018 Oct. Impact factor: 4.255 Publication type: Paper in international publication Authors: Buti, Maria, Cox, Stephanie, Parhy, Bandita, Zhou, Eric, Martin, Ross, Chang, Silvia, Lin, Lanjia, Flaherty, John F, Kitrinos, Kathryn M, Gaggar, Anuj et al. DOI: 10.1128/AAC.01064-18 No Resistance to Tenofovir Alafenamide Detected Through 96 Weeks of Treatment in Patients with Chronic Hepatitis B. PMID: 30038044 Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY Year: 2018 Reference: Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: AAC.01064-18. doi: 10.1128/AAC.01064-18. Print 2018 Oct. Impact factor: Publication type: Paper in international publication Authors: Bhardwaj, Neeru; Buti, Maria; Cathcart, Andrea L; Chan, Henry Lik-Yuen; Chang, Silvia; Cox, Stephanie; Flaherty, John F; Gaggar, Anuj; Izumi, Namiki; Kitrinos, Kathryn M et al. DOI: 10.1128/AAC.01064-18 Non traumatic giant aneurysm of middle meningeal artery. Case report and review of the literature. PMID: 29292165 Journal: NEUROCIRUGIA Year: 2018 Reference: Neurocirugia (Astur). 2018 Sep - Oct;29(5):250-254. doi: 10.1016/j.neucir.2017.11.003. Epub 2017 Dec 29. Impact factor: 0.31 Publication type: Paper in national publication Authors: Vilalta, Jordi, Martinez-Ricarte, Francisco, Martinez-Saez, Elena A, Gandara, Dario, Arikan, Fuat et al. DOI: 10.1016/j.neucir.2017.11.003 Non traumatic giant aneurysm of middle meningeal artery. Case report and review of the literature. PMID: 29292165 Journal: NEUROCIRUGIA Year: 2018 Reference: Neurocirugia (Astur). 2018 Sep - Oct;29(5):250-254. doi: 10.1016/j.neucir.2017.11.003. Epub 2017 Dec 29. Impact factor: Publication type: Paper in national publication Authors: Arikan, Fuat; Gandara, Dario; Martinez-Ricarte, Francisco; Martinez-Saez, Elena A; Vilalta, Jordi et al. DOI: 10.1016/j.neucir.2017.11.003 Non-Commercial versus Commercial Clinical Trials: a Retrospective Study of the Applications Submitted to a Research Ethics Committee. PMID: 29446851 Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY Year: 2018 Reference: Br J Clin Pharmacol. 2018 Jun;84(6):1384-1388. doi: 10.1111/bcp.13555. Epub 2018 Mar 22. Impact factor: 3.838 Publication type: Paper in international publication Authors: Fuentes Camps, Inmaculada, Rodriguez, Alexis, Agusti, Antonia et al. DOI: 10.1111/bcp.13555 Non-Commercial versus Commercial Clinical Trials: a Retrospective Study of the Applications Submitted to a Research Ethics Committee. PMID: 29446851 Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY Year: 2018 Reference: Br J Clin Pharmacol. 2018 Jun;84(6):1384-1388. doi: 10.1111/bcp.13555. Epub 2018 Mar 22. Impact factor: Publication type: Paper in international publication Authors: Agusti, Antonia; Fuentes Camps, Inmaculada; Rodriguez, Alexis et al. DOI: 10.1111/bcp.13555 Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. PMID: 29697741 Journal: ANNALS OF ONCOLOGY Year: 2018 Reference: Ann Oncol. 2018 Oct 1;29(Suppl 4):iv1-iv18. doi: 10.1093/annonc/mdy001. Impact factor: 13.926 Publication type: Paper in international publication Authors: Ray-Coquard, I, Morice, P, Lorusso, D, Prat, J, Oaknin, A, Pautier, P, Colombo, N et al. DOI: 10.1093/annonc/mdy001 Pagination First page « First Previous page ‹ Previous … Page 891 Page 892 Page 893 Page 894 Current page 895 Page 896 Page 897 Page 898 Page 899 … Next page Next › Last page Last »
